These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37862385)

  • 1. Quantitative mapping of the in vivo O-GalNAc glycoproteome in mouse tissues identifies GalNAc-T2 O-glycosites in metabolic disorder.
    Yang W; Tian E; Chernish A; McCluggage P; Dalal K; Lara A; Ten Hagen KG; Tabak LA
    Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2303703120. PubMed ID: 37862385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo mapping of the mouse Galnt3-specific O-glycoproteome.
    Dalal K; Yang W; Tian E; Chernish A; McCluggage P; Lara AJ; Ten Hagen KG; Tabak LA
    J Biol Chem; 2024 Sep; 300(9):107628. PubMed ID: 39098533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the
    Hintze J; Ye Z; Narimatsu Y; Madsen TD; Joshi HJ; Goth CK; Linstedt A; Bachert C; Mandel U; Bennett EP; Vakhrushev SY; Schjoldager KT
    J Biol Chem; 2018 Dec; 293(49):19064-19077. PubMed ID: 30327431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells.
    Vakhrushev SY; Steentoft C; Vester-Christensen MB; Bennett EP; Clausen H; Levery SB
    Mol Cell Proteomics; 2013 Apr; 12(4):932-44. PubMed ID: 23399548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
    Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
    J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells.
    Sheta R; Woo CM; Roux-Dalvai F; Fournier F; Bourassa S; Droit A; Bertozzi CR; Bachvarov D
    J Proteomics; 2016 Aug; 145():91-102. PubMed ID: 27095597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
    Steentoft C; Vakhrushev SY; Joshi HJ; Kong Y; Vester-Christensen MB; Schjoldager KT; Lavrsen K; Dabelsteen S; Pedersen NB; Marcos-Silva L; Gupta R; Bennett EP; Mandel U; Brunak S; Wandall HH; Levery SB; Clausen H
    EMBO J; 2013 May; 32(10):1478-88. PubMed ID: 23584533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.
    Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H
    Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.
    Schjoldager KT; Joshi HJ; Kong Y; Goth CK; King SL; Wandall HH; Bennett EP; Vakhrushev SY; Clausen H
    EMBO Rep; 2015 Dec; 16(12):1713-22. PubMed ID: 26566661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Click-iG: Simultaneous Enrichment and Profiling of Intact N-linked, O-GalNAc, and O-GlcNAcylated Glycopeptides.
    Liu J; Cheng B; Fan X; Zhou X; Wang J; Zhou W; Li H; Zeng W; Yang P; Chen X
    Angew Chem Int Ed Engl; 2023 Sep; 62(36):e202303410. PubMed ID: 37431278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global O-glycoproteome enrichment and analysis enabled by a combinatorial enzymatic workflow.
    Kang T; Budhraja R; Kim J; Joshi N; Garapati K; Pandey A
    Cell Rep Methods; 2024 Apr; 4(4):100744. PubMed ID: 38582075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in mass spectrometry driven O-glycoproteomics.
    Levery SB; Steentoft C; Halim A; Narimatsu Y; Clausen H; Vakhrushev SY
    Biochim Biophys Acta; 2015 Jan; 1850(1):33-42. PubMed ID: 25284204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Regulation of Protein O-Glycosylation in Isogenic Human HEK293 Cells by Differential O-Glycoproteomics.
    Narimatsu Y; Joshi HJ; Schjoldager KT; Hintze J; Halim A; Steentoft C; Nason R; Mandel U; Bennett EP; Clausen H; Vakhrushev SY
    Mol Cell Proteomics; 2019 Jul; 18(7):1396-1409. PubMed ID: 31040225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
    Schjoldager KT; Vakhrushev SY; Kong Y; Steentoft C; Nudelman AS; Pedersen NB; Wandall HH; Mandel U; Bennett EP; Levery SB; Clausen H
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9893-8. PubMed ID: 22566642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Schjoldager KT; Clausen H
    Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative characterization of O-GalNAc glycosylation.
    Čaval T; de Haan N; Konstantinidi A; Vakhrushev SY
    Curr Opin Struct Biol; 2021 Jun; 68():135-141. PubMed ID: 33508547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis.
    Verzijl CRC; Oldoni F; Loaiza N; Wolters JC; Rimbert A; Tian E; Yang W; Struik D; Smit M; Kloosterhuis NJ; Fernandez AJ; Samara NL; Ten Hagen KG; Dalal K; Chernish A; McCluggage P; Tabak LA; Jonker JW; Kuivenhoven JA
    Mol Metab; 2022 Jun; 60():101472. PubMed ID: 35304331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.
    Bagdonaite I; Nordén R; Joshi HJ; King SL; Vakhrushev SY; Olofsson S; Wandall HH
    J Biol Chem; 2016 Jun; 291(23):12014-28. PubMed ID: 27129252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
    Kong Y; Joshi HJ; Schjoldager KT; Madsen TD; Gerken TA; Vester-Christensen MB; Wandall HH; Bennett EP; Levery SB; Vakhrushev SY; Clausen H
    Glycobiology; 2015 Jan; 25(1):55-65. PubMed ID: 25155433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypeptide
    Kato K; Hansen L; Clausen H
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.